VBI-002

N/A

Report date: 2025/01/26 17:40:06

Base Information

Drug NameVBI-002

Drug Alias NameCD47 checkpoint inhibitor/anti-ICAM-1 bispecific antibody (Virtuoso Therapeutics)VBI-002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 47 inhibitorsIntercellular adhesion molecule-1 modulators

TargetsIntercellular adhesion molecule-1Cluster of differentiation 47

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVirtuoso Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVirtuoso Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A